Emmanuelle Weiller

1.2k total citations
35 papers, 777 citations indexed

About

Emmanuelle Weiller is a scholar working on Pharmacology, Psychiatry and Mental health and Experimental and Cognitive Psychology. According to data from OpenAlex, Emmanuelle Weiller has authored 35 papers receiving a total of 777 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pharmacology, 19 papers in Psychiatry and Mental health and 17 papers in Experimental and Cognitive Psychology. Recurrent topics in Emmanuelle Weiller's work include Treatment of Major Depression (26 papers), Schizophrenia research and treatment (14 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (12 papers). Emmanuelle Weiller is often cited by papers focused on Treatment of Major Depression (26 papers), Schizophrenia research and treatment (14 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (12 papers). Emmanuelle Weiller collaborates with scholars based in Denmark, United States and Japan. Emmanuelle Weiller's co-authors include Catherine Weiss, Mary Hobart, Y. Lecrubier, Peter Zhang, John Ouyang, Ross A. Baker, Roger S. McIntyre, Cornelius Katona, Philip Gorwood and Aleksandar Skuban and has published in prestigious journals such as Journal of Affective Disorders, Schizophrenia Bulletin and Schizophrenia Research.

In The Last Decade

Emmanuelle Weiller

35 papers receiving 743 citations

Peers

Countries citing papers authored by Emmanuelle Weiller

Since Specialization

Citations

This map shows the geographic impact of Emmanuelle Weiller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmanuelle Weiller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmanuelle Weiller more than expected).

Fields of papers citing papers by Emmanuelle Weiller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emmanuelle Weiller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmanuelle Weiller. The network helps show where Emmanuelle Weiller may publish in the future.

Co-authorship network of co-authors of Emmanuelle Weiller

This figure shows the co-authorship network connecting the top 25 collaborators of Emmanuelle Weiller. A scholar is included among the top collaborators of Emmanuelle Weiller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emmanuelle Weiller. Emmanuelle Weiller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The effects of brexpiprazole and aripiprazole on body weight as monotherapy in patients with schizophrenia and as adjunctive treatment in patients with major depressive disorder 2018 ·International Clinical Psychopharmacology ·Catherine Weiss, Emmanuelle Weiller, Ross A. Baker, Ruth A. Duffy, (unknown), Peter Zhang, Robert D. McQuade	21
2	Successful switching of patients with acute schizophrenia from another antipsychotic to brexpiprazole: comparison of clinicians’ choice of cross-titration schedules in a post hoc analysis of a randomized, double-blind, maintenance treatment study 2018 ·CNS Spectrums ·Christoph U. Correll, (unknown), Catherine Weiss, Mary Hobart, Anna Eramo, Ruth A. Duffy, Emmanuelle Weiller, Ross A. Baker	13
3	Efficacy of adjunctive brexpiprazole on the core symptoms of major depressive disorder: A post hoc analysis of two pooled clinical studies 2017 ·Journal of Affective Disorders ·J. Craig Nelson, Emmanuelle Weiller, Peter Zhang, Catherine Weiss, Mary Hobart	12
4	Functioning outcomes with adjunctive treatments for major depressive disorder: a systematic review of randomized placebo-controlled studies 2017 ·Neuropsychiatric Disease and Treatment ·Emmanuelle Weiller, Catherine Weiss, (unknown), (unknown), Mary Hobart, Hans Eriksson, Maurizio Fava	12
5	Switching from Inadequate Adjunctive or Combination Treatment Options to Brexpiprazole Adjunctive to Antidepressant: An Open-Label Study on the Effects on Depressive Symptoms and Cognitive and Physical Functioning 2016 ·The International Journal of Neuropsychopharmacology ·Maurizio Fava, (unknown), Yuki Matsushima, Pamela Perry, Emmanuelle Weiller, Ross A. Baker	14
6	Suicidality and symptoms of anxiety, irritability, and agitation in patients experiencing manic episodes with depressive symptoms: a naturalistic study 2016 ·Neuropsychiatric Disease and Treatment ·Jonas Eberhard, Emmanuelle Weiller	15
7	Adjunctive brexpiprazole in patients with major depressive disorder and anxiety symptoms: an exploratory study 2016 ·Brain and Behavior ·Lori L. Davis, (unknown), Pamela Perry, (unknown), Emmanuelle Weiller, Ross A. Baker	19
8	The effect of brexpiprazole in adult outpatients with early-episode schizophrenia 2016 ·International Clinical Psychopharmacology ·Ashok Malla, (unknown), (unknown), Pamela Perry, Emmanuelle Weiller, Ross A. Baker	13
9	Brexpiprazole in patients with schizophrenia: overview of short- and long-term phase 3 controlled studies 2016 ·Acta Neuropsychiatrica ·Stephen R. Marder, (unknown), Mette Krog Josiassen, Peter Zhang, John Ouyang, Emmanuelle Weiller, Catherine Weiss, Mary Hobart	29
10	Brexpiprazole as an adjunctive treatment in young adults with major depressive disorder who are in a school or work environment 2016 ·Journal of Affective Disorders ·Richard H. Weisler, (unknown), (unknown), Pamela Perry, Emmanuelle Weiller, Ross A. Baker, David V. Sheehan	13
11	The effect of brexpiprazole (OPC-34712) and aripiprazole in adult patients with acute schizophrenia 2016 ·International Clinical Psychopharmacology ·Leslie Citrome, (unknown), (unknown), Pamela Perry, Emmanuelle Weiller, Ross A. Baker	49
12	Efficacy and Safety of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults with Schizophrenia: a Randomized, Double-Blind, Placebo-Controlled Study 2016 ·The International Journal of Neuropsychopharmacology ·W. Wolfgang Fleischhacker, Mary Hobart, John Ouyang, Andrew Forbes, Stephanie Pfister, Robert D. McQuade, William H. Carson, Raymond Sanchez, (unknown), Emmanuelle Weiller	67
13	Efficacy of brexpiprazole in patients with acute schizophrenia: Review of three randomized, double-blind, placebo-controlled studies 2016 ·Schizophrenia Research ·Christoph U. Correll, Aleksandar Skuban, Mary Hobart, John Ouyang, Emmanuelle Weiller, Catherine Weiss, John M. Kane	44
14	Real-World Determinants of Adjunctive Antipsychotic Prescribing for Patients with Major Depressive Disorder and Inadequate Response to Antidepressants: A Case Review Study 2015 ·Advances in Therapy ·Roger S. McIntyre, Emmanuelle Weiller	21
15	Evaluating depressive symptoms in hypomanic and manic episodes using a structured diagnostic tool: validation of a new Mini International Neuropsychiatric Interview (M.I.N.I.) module for the DSM-5 'With Mixed Features’ specifier 2013 ·International Journal of Bipolar Disorders ·(unknown), Emmanuelle Weiller	35
16	Are old-old patients with major depression more likely to relapse than young-oldpatients during continuation treatment with escitalopram? 2011 ·BMC Geriatrics ·Constantine G. Lyketsos, Emmanuelle Weiller, Cornelius Katona, Philip Gorwood	12
17	Escitalopram Therapy for Major Depression and Anxiety Disorders 2007 ·Annals of Pharmacotherapy ·David S. Baldwin, Elin Heldbo Reines, (unknown), Emmanuelle Weiller	52
18	Escitalopram Prevents Relapse in Older Patients With Major Depressive Disorder 2007 ·American Journal of Geriatric Psychiatry ·Philip Gorwood, Emmanuelle Weiller, Ole Lemming, Cornelius Katona	69
19	Recurrent brief depression: A frequent syndrome in clinical practice 2000 ·International Journal of Psychiatry in Clinical Practice ·Jules Angst, Siegfried Kasper, Emmanuelle Weiller	5
20	Recurrent Brief Depression: Clinical and Epidemiological Issues 1995 ·Psychopathology ·(unknown), Antoine Pélissolo, Emmanuelle Weiller, (unknown), Y. Lecrubier	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact